A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancer
{{output}}
Background: The last decade saw the emergence of several new systemic therapies for metastatic hormone-sensitive prostate cancer (mHSPC). While these treatments demonstrated similar efficacy in indirect comparisons, comparisons o... ...
